AstraZeneca
AZN
AZN
557 hedge funds and large institutions have $19.3B invested in AstraZeneca in 2019 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 141 increasing their positions, 228 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 556 → 557 (+1)
10% less call options, than puts
Call options by funds: $91.5M | Put options by funds: $101M
38% less repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 228
Holders
557
Holding in Top 10
6
Calls
$91.5M
Puts
$101M
Top Buyers
| 1 | +$253M | |
| 2 | +$210M | |
| 3 | +$100M | |
| 4 |
O
OppenheimerFunds
New York
|
+$97.2M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$87M |
Top Sellers
| 1 | -$249M | |
| 2 | -$108M | |
| 3 | -$102M | |
| 4 |
Jennison Associates
New York
|
-$94.4M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$48M |